Singapore, Nov. 21 -- Australia's Telix Pharmaceuticals has announced the official opening of Telix Manufacturing Solutions (TMS) inYokohama, Japan, the company's first cyclotron facility in theAsia Pacificregion (APAC).

TMSYokohamawill enable Telix to provide greater access to radiopharmaceuticals for Japanese patients, initially through clinical supply of TLX250-CDx (a kidney cancer imaging candidate), with plans to supply other Telix investigational and future commercial products, including prostate and brain cancer precision diagnostics and therapies, subject to regulatory approval.

A commemorative lecture was held to mark the occasion, delivered by ProfessorJun Hatazawa, Vice President of the Japan Isotope Association and Professor...